Page 26 - Product Testing News Today

Press release content from Newswire. The AP news staff was not involved in its creation. Philogen Announces Participation to the 10th World Congress of Melanoma April 12, 2021 GMT Philogen Announces Participation to the 10th World Congress of Melanoma SIENA, Italy - April 12, 2021 - ( Newswire.com ) Philogen S.p.A., a listed clinical-stage biotechnology company focused on the development of innovative medicines based on tumor-targeting antibodies and small molecule ligands, is pleased to announ...

Press release content from Business Wire. The AP news staff was not involved in its creation. Gemini Therapeutics Appoints Samuel Barone, M.D., as Chief Medical Officer April 12, 2021 GMT CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 12, 2021-- Gemini Therapeutics, Inc. (Nasdaq: GMTX), a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD) and linked ocular disorders, today announced the appointment of Samuel Barone, ...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Biofrontera reports results for the 2020 financial year Biofrontera AGApril 12, 2021 GMT Leverkusen, Germany, April 12, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its consolidated results for the fiscal year ended December 31, 2020. At the same time, the Company provided an overvi...

Press release content from Business Wire. The AP news staff was not involved in its creation. BeiGene Presents Clinical Data on Sitravatinib in Combination with Tislelizumab at the AACR Annual Meeting 2021 April 11, 2021 GMT CAMBRIDGE, Mass. & BEIJING--(BUSINESS WIRE)--Apr 11, 2021-- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that clinical data on its anti-PD-1 anti...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Evaxion Biotech Announces Q4 and Full-Year 2020 Financial Results and Provides Business Update Evaxion BiotechApril 6, 2021 GMT Successfully completed initial public offering on U.S. Nasdaq in February 2021, raising gross proceeds of $30 million Clinical development on track with dosing of first patient in Phase 1/2a melanoma trial of cancer vaccine EVX-02 Cash reserves of $5.8 million at December 31...

Press release content from PR Newswire. The AP news staff was not involved in its creation. OBI Pharma Announces Poster Presentations at AACR 2021 Annual Meeting for OBI-3424, OBI-998, Globo H and SSEA-4 April 6, 2021 GMT TAIPEI, Taiwan, April 6, 2021 /PRNewswire/ -- OBI Pharma, Inc. (TPEx: 4174) today announced the data highlighting the characteristics and antitumor efficacy of OBI-3424 and animal studies of OBI-998, as well as the T-cell inhibitory roles of Globo-H and SSEA-4 in the tumor mic...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. AB Science announces the signing of an exclusive licensing agreement with the University of ... AB ScienceApril 6, 2021 GMT                                                                                                                                                                                           �...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Yumanity Therapeutics Announces Study Demonstrating In Vivo Efficacy of YTX-7739 in a ... Yumanity Therapeutics IncApril 6, 2021 GMT YTX-7739 demonstrates efficacy, including increased median overall survival, both as a single agent and in combination with temozolomide, the standard-of-care for GBM Shared therapeutic target with Parkinson’s disease expands potential utility of  YTX-7739 to non-neu...

Press release content from Business Wire. The AP news staff was not involved in its creation. Moderna Provides Storage Update & Announces the U.S. FDA Authorizes Up To 15-Doses Per Vial of its COVID-19 Vaccine April 2, 2021 GMT CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 1, 2021-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that based on submitted stability data, the U.S. Food and Drug Administration (FDA) has autho...

Press release content from Business Wire. The AP news staff was not involved in its creation. Quidel Supports New NIH, CDC Public Health Initiative for At-home COVID-19 Testing April 1, 2021 GMT SAN DIEGO--(BUSINESS WIRE)--Mar 31, 2021-- Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it is partnering with the Centers for Disease Control and Preventio...